{"slideshow_credits": null, "snippet": "The drugs work by unleashing the immune system to attack cancer cells, much as it attacks bacteria or other foreign invaders in the human body.", "abstract": "Early success of new class of cancer drugs raises hope among top cancer specialists that they may be on verge of important milestone; shares of Merck and Bristol-Myers Squibb, which are developing such drugs, rise more than 3 percent after data is presented; drugs work by unleashing the immune system to attack cancer cells, much as it attacks bacteria.", "section_name": "Health", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/06/04/health/promising-new-cancer-drugs-empower-the-bodys-own-defense-system.html", "lead_paragraph": "The drugs work by unleashing the immune system to attack cancer cells, much as it attacks bacteria or other foreign invaders in the human body.", "headline": {"main": "Promising New Cancer Drugs Empower the Body\u2019s Own Defense System", "print_headline": "Promising New Cancer Drugs Empower the Body\u2019s Own Defense System"}, "_id": "51ad390c40e9ec65d203b163", "word_count": "1230", "multimedia": [{"height": 126, "url": "images/2013/06/04/business/0604CANCER/0604CANCER-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/06/04/business/0604CANCER/0604CANCER-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 397, "url": "images/2013/06/04/business/0604CANCER/0604CANCER-articleLarge.jpg", "legacy": {"xlarge": "images/2013/06/04/business/0604CANCER/0604CANCER-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "397"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2013/06/04/business/0604CANCER/0604CANCER-thumbStandard.jpg", "legacy": {"thumbnail": "images/2013/06/04/business/0604CANCER/0604CANCER-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-06-04T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Cancer", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Immune System", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Melanomas", "name": "subject", "is_major": "N", "rank": "4"}, {"value": "Merck & Company Inc", "name": "organizations", "is_major": "Y", "rank": "5"}, {"value": "Bristol Myers Squibb Company", "name": "organizations", "is_major": "Y", "rank": "6"}], "blog": [], "subsection_name": null, "type_of_material": "News"}